{"content":"<li class=\"n-box-item date-title\" data-end=\"1380859199\" data-start=\"1380772800\" data-txt=\"Friday, December 20, 2019\">Thursday, October  3, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1313292\" data-ts=\"1380855860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PT-OLD\" target=\"_blank\">PT-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1313292-portugal-telecom-slides-following-citi-downgrade-oi-falls-harder\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Portugal Telecom slides following Citi downgrade, Oi falls harder</a></h4><ul>     <li>A day after Portugal Telecom (<a href=\"https://seekingalpha.com/symbol/PT-OLD\" title=\"Portugal Telecom SGPS SA\">PT-OLD</a> <font color=\"red\">-3.1%</font>) and Brazilian mobile unit Oi (OIBR <font color=\"red\">-13.1%</font>) both soared in response to the carriers' <a href=\"https://seekingalpha.com/currents/post/1309472\" target=\"_blank\">merger announcement</a>, PT fell with the help of a Citi downgrade to Neutral.</li>     <li>Oi fell harder, likely due to debt and <a href=\"https://seekingalpha.com/currents/post/1313062\" target=\"_blank\">Brazilian macro</a> concerns. <a href=\"http://www.streetinsider.com/Credit+Ratings/S%26P+Places+Oi+S.A.+%28OIBR%29+Ratings+on+CreditWatch+Negative+%28PT%29/8747049.html\" target=\"_blank\">S&amp;P has put</a> Oi's debt ratings (already BBB-) on watch for a downgrade, and points out the deal requires the carrier to raise R$7B-$8B ($3.16B-$3.62B) in capital. R$2.5B-$3.5B will be used to give Oi a cash infusion, while R$4.5B will be used to pay down existing debt.</li>     <li>Moody's is <a href=\"https://www.moodys.com/research/Moodys-affirms-Ois-Baa3Aa1br-rating-with-a-negative-outlook-following--PR_283488?WT.mc_id=NLTITLE_YYYYMMDD_PR_283488\" target=\"_blank\">maintaining</a> its Baa3 rating for Oi with a negative outlook, but is putting its Ba2 rating for PT <a href=\"https://www.moodys.com/research/Moodys-places-Ba2-ratings-of-Portugal-Telecom-on-review-for--PR_283286?WT.mc_id=NLTITLE_YYYYMMDD_PR_283286\" target=\"_blank\">on review</a> for an upgrade, citing Oi's guarantee to give PT bondholders to either have their debt paid off or converted into newly-issued bonds.</li>     <li>The agency also praises the merger's synergies, and expects the combined company to start producing positive free cash flow in 2015.</li>     <li>Also: Telecom Italia CEO Franco Bernabe has <a href=\"http://www.reuters.com/article/2013/10/03/us-telecomitalia-resignation-idUSBRE9920R320131003?feedType=RSS&amp;feedName=businessNews\" target=\"_blank\">resigned</a>. That should pave the way for TI to put its Brazilian unit <a href=\"http://www.bloomberg.com/news/2013-09-24/brazil-phone-watchdog-said-to-prefer-tim-sale-to-breakup.html\" target=\"_blank\">on the block</a>; many think a major foreign carrier such as AT&amp;T or Vodafone will end up buying it.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1313292\" data-linked=\"Portugal Telecom slides following Citi downgrade, Oi falls harder\" data-tweet=\"$PT-OLD $PT-OLD $OIBR.C - Portugal Telecom slides following Citi downgrade, Oi falls harder https://seekingalpha.com/news/1313292-portugal-telecom-slides-following-citi-downgrade-oi-falls-harder?source=tweet\" data-url=\"https://seekingalpha.com/news/1313292-portugal-telecom-slides-following-citi-downgrade-oi-falls-harder\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1313262\" data-ts=\"1380855365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCP\" target=\"_blank\">HCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1313262-more-cockroaches-at-hcp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More cockroaches at HCP?</a></h4><ul>\n<li>\"Something <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/10/03/hcp-falls-4-as-investors-ponder-sudden-ceo-firing/?mod=yahoobarrons\" target=\"_blank\">doesn't feel right to us</a>,\" says Citigroup's Emmanuel Korchman, opining on the <a href=\"https://seekingalpha.com/currents/post/1312312\" target=\"_blank\">boardroom coup</a> at HCP Inc. (<a href=\"https://seekingalpha.com/symbol/HCP\" title=\"HCP, Inc.\">HCP</a> <font color=\"red\">-4.7%</font>) this morning. New Non-Executive Chairman Mike McKee says the move was not about operating concerns or share performance, and the company says there are neither financial issues nor other shoes to drop.</li>\n<li>Korchman tallies up former CEO Jay Flaherty's severance with new CEO Lauralee Martin's inducement and retention payments, and its sums to more than $50M in stock and cash - a not-insignificant amount.</li>\n<li>\"In an industry where relationships and capital are key ingredients for success, questions about the change will likely put HCP at a disadvantage in the near term vs. its 2 largest peers, Ventas (<a href=\"https://seekingalpha.com/symbol/VTR\" title=\"Ventas Inc.\">VTR</a> <font color=\"red\">-2.3%</font>) and Health Care REIT (HCN <font color=\"red\">-1.9%</font>), which can continue the industry\u2019s consolidation.\"</li>\n<li>Korchman continues to prefer Ventas in this space thanks to \"its tenured and collaborative management team, deep bench, strong tenant and capital relationships, deal expertise and track record of success.\" HCP shares, says Korchman, have not yet priced in the new risks on the table.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1313262\" data-linked=\"More cockroaches at HCP?\" data-tweet=\"$HCP $PEAK $VTR - More cockroaches at HCP? https://seekingalpha.com/news/1313262-more-cockroaches-at-hcp?source=tweet\" data-url=\"https://seekingalpha.com/news/1313262-more-cockroaches-at-hcp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1313102\" data-ts=\"1380820599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1313102-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Top 10 Gainers:</b> <a href=\"https://seekingalpha.com/symbol/OINK\" title=\"Tianli Agritech, Inc.\">OINK</a> <font color=\"green\">+30%</font>. <a href=\"https://seekingalpha.com/symbol/GWPH\" title=\"GW Pharmaceuticals plc\">GWPH</a> <font color=\"green\">+22%</font>. <a href=\"https://seekingalpha.com/symbol/EVK\" title=\"Ever-Glory International Group, Inc\">EVK</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/OMER\" title=\"Omeros Corporation\">OMER</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/PRIS\" title=\"Promotora de Informaciones, S.A.\">PRIS</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/EDAP\" title=\"EDAP TMS S.A.\">EDAP</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/CAMP\" title=\"CalAmp Corp.\">CAMP</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/INFU\" title=\"InfuSystem Holdings, Inc.\">INFU</a> <font color=\"green\">+12%</font>. ICGE <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/BIOA\" title=\"BioAmber\">OTC:BIOA</a> <font color=\"green\">+11%</font>.</li>\n<li>\n<b>Top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/CEVA\" title=\"CEVA, Inc.\">CEVA</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/ANGI\" title=\"ANGI Homeservices Inc.\">ANGI</a> <font color=\"red\">-15%</font>. ZLCS <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/TXI\" title=\"Texas Industries\">TXI</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/NURO\" title=\"NeuroMetrix, Inc.\">NURO</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/ZLC\" title=\"Zale Corporation\">ZLC</a> <font color=\"red\">-10%</font>. DXM <font color=\"red\">-10%</font>. PSDV <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/ICEL\" title=\"Cellular Dynamics International, Inc.\">ICEL</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/CERE\" title=\"Ceres, Inc.\">CERE</a> <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1313102\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$OINK $GWPH $EVK - Midday Gainers / Losers https://seekingalpha.com/news/1313102-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1313102-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1313072\" data-ts=\"1380820313\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQIX\" target=\"_blank\">EQIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1313072-equinix-slides-after-upsizing-amending-credit-facilities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Equinix slides after upsizing, amending credit facilities</a></h4><ul>\n<li>Equinix (<a href=\"https://seekingalpha.com/symbol/EQIX\" title=\"Equinix, Inc.\">EQIX</a> <font color=\"red\">-5.1%</font>) has added $250M to its revolving credit facility, increasing its size to $800M, and amended both the revolving credit facility and a $200M term loan facility to make them more REIT-friendly. (PR)</li>\n<li>Equinix says the amendment will give it \"greater flexibility to make pre-REIT conversion purge distributions and post-REIT conversion cash dividends necessary to comply with REIT rules and regulations if the company is successful in its REIT conversion.\" Certain financial covenants have also been amended, as spelled out in an <a href=\"http://biz.yahoo.com/e/131002/eqix8-k.html\" target=\"_blank\">8-K</a>.</li>\n<li>The data center owner <a href=\"https://seekingalpha.com/currents/post/537051\" target=\"_blank\">originally announced</a> plans to convert into a REIT a year ago; investors gave a resounding thumbs-up. Shares sold off in June after <a href=\"https://seekingalpha.com/currents/post/1070451\" target=\"_blank\">Iron Mountain</a> disclosed the IRS is \"tentatively adverse\" to its own conversion plans.</li>\n<li>Equinix had $3.94B in debt on its <a href=\"http://finance.yahoo.com/q/bs?s=EQIX\" target=\"_blank\">balance sheet</a> as of June 30, and $1.22B in cash/investments. The company has seen <a href=\"http://finance.yahoo.com/q/cf?s=EQIX&amp;annual\" target=\"_blank\">negative free cash flow</a> each of its last three fiscal years, as heavy capex (driven by data center construction) offset solid operating cash flow.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1313072\" data-linked=\"Equinix slides after upsizing, amending credit facilities\" data-tweet=\"$EQIX - Equinix slides after upsizing, amending credit facilities https://seekingalpha.com/news/1313072-equinix-slides-after-upsizing-amending-credit-facilities?source=tweet\" data-url=\"https://seekingalpha.com/news/1313072-equinix-slides-after-upsizing-amending-credit-facilities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1313252\" data-ts=\"1380817365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBL\" target=\"_blank\">NBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1313252-cyprus-gas-field-smaller-than-initial-estimate-noble-energy-minus-3_2-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cyprus gas field smaller than initial estimate, Noble Energy -3.2%</a></h4><ul>     <li>Enthusiasm that might have ensued from Noble Energy's (<a href=\"https://seekingalpha.com/symbol/NBL\" title=\"Noble Energy, Inc.\">NBL</a> <font color=\"red\">-3.2%</font>) announcement of <a href=\"https://seekingalpha.com/currents/post/1312372\" target=\"_blank\">significantly more gas</a> to its gross reserves estimate offshore Cyprus is tempered by word from the country's energy minister that the gas field off the southern coast contains 3.6T-6T cf, <a href=\"http://fuelfix.com/blog/2013/10/03/cyprus-gas-field-smaller-than-initial-estimate/\" target=\"_blank\">less than an earlier estimate</a> of 5T-8T.</li>     <li>A second appraisal well to specify gas quantities in the field will be  needed, which may cause delays in building a gas processing facility to export excess supply, the minister says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1313252\" data-linked=\"Cyprus gas field smaller than initial estimate, Noble Energy -3.2%\" data-tweet=\"$NBL - Cyprus gas field smaller than initial estimate, Noble Energy -3.2% https://seekingalpha.com/news/1313252-cyprus-gas-field-smaller-than-initial-estimate-noble-energy-minus-3_2-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1313252-cyprus-gas-field-smaller-than-initial-estimate-noble-energy-minus-3_2-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1313022\" data-ts=\"1380815938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUSA\" target=\"_blank\">HUSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1313022-houston-american-to-drill-test-wells-on-three-prospects\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Houston American to drill test wells on three prospects</a></h4><ul>     <li>In an update of its drilling plans, Houston American Energy (<a href=\"https://seekingalpha.com/symbol/HUSA\" title=\"Houston American Energy Corp.\">HUSA</a> <font color=\"green\">+8.4%</font>) says it has agreed to participate in the drilling of test wells on three prospects in Texas and Louisiana, each expected to occur before year-end 2013.</li>     <li>HUSA had already announced plans to participate in drilling a 10K-ft. test well in Pecos County, Texas.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1313022\" data-linked=\"Houston American to drill test wells on three prospects\" data-tweet=\"$HUSA - Houston American to drill test wells on three prospects https://seekingalpha.com/news/1313022-houston-american-to-drill-test-wells-on-three-prospects?source=tweet\" data-url=\"https://seekingalpha.com/news/1313022-houston-american-to-drill-test-wells-on-three-prospects\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1313012\" data-ts=\"1380815749\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEAC\" target=\"_blank\">SEAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1313012-seachange-spikes-on-brean-murray-m-and-a-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SeaChange spikes on Brean Murray M&amp;A note</a></h4><ul>\n<li>SeaChange (<a href=\"https://seekingalpha.com/symbol/SEAC\" title=\"SeaChange International, Inc.\">SEAC</a> <font color=\"green\">+5.5%</font>) shares jump after Brean Murray <a href=\"https://twitter.com/financialjuice/status/385784994809274368\" target=\"_blank\">releases </a>a note on why the boutique believes the company will be bought out at $20/share (implying a 72% premium from yesterday's close).</li>\n<li>Following the note, SEAC jumped to just shy of 52-week highs notched in July before fading slightly.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1313012\" data-linked=\"SeaChange spikes on Brean Murray M&amp;A note\" data-tweet=\"$SEAC - SeaChange spikes on Brean Murray M&amp;A note https://seekingalpha.com/news/1313012-seachange-spikes-on-brean-murray-m-and-a-note?source=tweet\" data-url=\"https://seekingalpha.com/news/1313012-seachange-spikes-on-brean-murray-m-and-a-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312932\" data-ts=\"1380813628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAXN\" target=\"_blank\">AAXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312932-taser-lowers-prices-shares-sink\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taser lowers prices, shares sink</a></h4><ul>\n<li>The Taser (TASR <font color=\"red\">-7.6%</font>) <a href=\"https://seekingalpha.com/symbol/tasr/currents\" target=\"_blank\">rally</a> comes to a screeching halt Thursday, as the company announces price cuts.</li>\n<li>The price of the AXON flex is now $499 ($949 previously).</li>\n<li>The price of EVIDENCE.com service has been reduced to a starting price of $9.95/month.</li>\n<li>\"Every officer deserves protection and price should not be a barrier,\" EVIDENCE.com president Jason Droege says, adding that \"all officers can [now] afford the protection they deserve.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1312932\" data-linked=\"Taser lowers prices, shares sink\" data-tweet=\"$AAXN - Taser lowers prices, shares sink https://seekingalpha.com/news/1312932-taser-lowers-prices-shares-sink?source=tweet\" data-url=\"https://seekingalpha.com/news/1312932-taser-lowers-prices-shares-sink\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312842\" data-ts=\"1380812208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISRG\" target=\"_blank\">ISRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312842-citron-follow-up-hits-intuitive-surgical\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron &quot;follow up&quot; hits Intuitive Surgical</a></h4><ul>\n<li>Citron is out with another negative piece (a \"follow up\" they call it) on Intuitive Surgical (<a href=\"https://seekingalpha.com/symbol/ISRG\" title=\"Intuitive Surgical, Inc.\">ISRG</a> <font color=\"red\">-2.2%</font>).</li>\n<li>Notably, the report flags what appears to be a dramatic increase in AE reports for the da Vinci during the first five months of this year.</li>\n<li>According to Citron, the number of injury or death reports rose to an unprecedented monthly total in August due apparently to \" a mass posting of 73 events which are annotated 'as part of a legal mediation effort.'\" Citron wonders why there seems to be a one to four year time lag between the event dates and event reports, and says \"a reasonable investor would anticipate that reams of litigation disclosure will be made public in the company's [upcoming] 10Q.\"</li>\n<li>Finally, Citron wants to know why no one on Wall Street is considering the possibility that the company \"could stop growing entirely for the foreseeable future.\"</li>\n<li>Price target is now $200.</li>\n<li><a href=\"http://www.citronresearch.com/wp-content/uploads/2013/10/Intuitive-Surgical-Oct-2013-Maude-Update-Final.pdf\" target=\"_blank\">Full report</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1312842\" data-linked=\"Citron &quot;follow up&quot; hits Intuitive Surgical\" data-tweet=\"$ISRG - Citron &quot;follow up&quot; hits Intuitive Surgical https://seekingalpha.com/news/1312842-citron-follow-up-hits-intuitive-surgical?source=tweet\" data-url=\"https://seekingalpha.com/news/1312842-citron-follow-up-hits-intuitive-surgical\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312822\" data-ts=\"1380811760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEVA\" target=\"_blank\">CEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312822-ceva-plunges-on-q3-earnings-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CEVA plunges on Q3 earnings warning</a></h4><ul>\n<li>CEVA (<a href=\"https://seekingalpha.com/symbol/CEVA\" title=\"CEVA, Inc.\">CEVA</a> <font color=\"red\">-15.9%</font>) shares plunge after it issues an earnings warning for Q3. Management now expects revenue of $10M vs. prior guidance of $11.5M-$12.5M and consensus of $12.1M.</li>\n<li>CEO Gideon Wertheizer: \"Our licensing and related revenues came in lower than projected for the third quarter due mainly to not closing a significant license agreement.\"</li>\n<li>Q3 opex is expected to be $600K higher than previously guided due to a delay in R&amp;D grants in Israel, which are now expected in Q4.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1312822\" data-linked=\"CEVA plunges on Q3 earnings warning\" data-tweet=\"$CEVA - CEVA plunges on Q3 earnings warning https://seekingalpha.com/news/1312822-ceva-plunges-on-q3-earnings-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/1312822-ceva-plunges-on-q3-earnings-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312802\" data-ts=\"1380811124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACTA\" target=\"_blank\">ACTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312802-accenture-buys-outsourcing-firm-procurian-from-icg-for-375m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accenture buys outsourcing firm Procurian from ICG for $375M</a></h4><ul>\n<li>Procurian has 780 employees, and <a href=\"http://www.procurian.com/what-we-do\" target=\"_blank\">offers</a> procurement-related BPO services. The all-cash deal is expected to close by year's end. ICG (ICGE <font color=\"green\">+13.3%</font>), which had a market cap of only $527M going into today, has jumped on the news. (PR)</li>\n<li>Accenture (<a href=\"https://seekingalpha.com/symbol/ACN\" title=\"Accenture plc\">ACN</a> <font color=\"red\">-0.4%</font>), which has been buying companies at an increasingly frequent pace as organic growth <a href=\"https://seekingalpha.com/currents/post/1301552\" target=\"_blank\">slows</a>, says Procurian will augment its existing procurement BPO offerings. In particular, Accenture touts the company's strategic sourcing, analytics, and delivery capabilities.</li>\n<li>Procurian is based out of Pennsylvania, has <a href=\"http://www.procurian.com/how-we-deliver/global-operations\" target=\"_blank\">delivery locations</a> in the U.S. and several other countries.</li>\n<li>Recent Accenture acquisitions: <a href=\"https://seekingalpha.com/currents/post/1215272\" target=\"_blank\">Prion Group</a>, <a href=\"https://seekingalpha.com/currents/post/1281682\" target=\"_blank\">Vivere Brasil</a>, <a href=\"https://seekingalpha.com/currents/post/1033711\" target=\"_blank\">Acquity Group</a>, <a href=\"https://seekingalpha.com/currents/post/1138522\" target=\"_blank\">Mortgage Cadence</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1312802\" data-linked=\"Accenture buys outsourcing firm Procurian from ICG for $375M\" data-tweet=\"$ACTA $ACTA $ACN - Accenture buys outsourcing firm Procurian from ICG for $375M https://seekingalpha.com/news/1312802-accenture-buys-outsourcing-firm-procurian-from-icg-for-375m?source=tweet\" data-url=\"https://seekingalpha.com/news/1312802-accenture-buys-outsourcing-firm-procurian-from-icg-for-375m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312782\" data-ts=\"1380810771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312782-ramey-predicts-herbalife-rally-calls-ackmans-put-counterparty-lucky\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ramey predicts Herbalife rally, calls Ackman&#39;s put counterparty &quot;lucky&quot;</a></h4><ul>\n<li>Fresh off a mention in Pershing Square's investor <a href=\"http://thenypost.files.wordpress.com/2013/10/3q13-investor-letter.pdf\" target=\"_blank\">letter</a>, DA Davidson's Tim Ramey is out with some commentary on Bill Ackman's <a href=\"https://seekingalpha.com/currents/post/1311732\" target=\"_blank\">move to restructure</a> his bet against Herbalife (<a href=\"https://seekingalpha.com/symbol/HLF\" title=\"Herbalife Ltd.\">HLF</a> <font color=\"red\">-4.7%</font>).</li>\n<li>Ramey calls the counterparty to Ackman's puts \"<a href=\"http://www.streetinsider.com/Analyst+Comments/Ackman%27s+Nemesis+Speaks+About+Herbalife+%28HLF%29+Short+Covering%2C+Thinks+Puts+Expire+Worthless/8746696.html\" target=\"_blank\">lucky</a>\" and says \"it is highly likely that these puts will expire worthless.\"</li>\n<li>\"If [Pershing Square] truly still believes the go-to-zero thesis, and Mr. Ackman writes  in his letter that he does, then it makes no sense to put a time  element into this trade,\" Ramey adds.</li>\n<li>For once, Ramey's prediction about the direction of the stock's price seems to be incorrect: \"We would anticipate that the volume will be huge in the next five trading sessions and the stock may move much higher.\" The shares are down markedly in morning trading.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1312782\" data-linked=\"Ramey predicts Herbalife rally, calls Ackman&#39;s put counterparty &quot;lucky&quot;\" data-tweet=\"$HLF - Ramey predicts Herbalife rally, calls Ackman&#39;s put counterparty &quot;lucky&quot; https://seekingalpha.com/news/1312782-ramey-predicts-herbalife-rally-calls-ackmans-put-counterparty-lucky?source=tweet\" data-url=\"https://seekingalpha.com/news/1312782-ramey-predicts-herbalife-rally-calls-ackmans-put-counterparty-lucky\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312742\" data-ts=\"1380810326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASTI\" target=\"_blank\">ASTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312742-ascent-solar-accessories-available-at-wal-mart-shares-fly\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ascent Solar accessories available at Wal-mart, shares fly</a></h4><ul>\n<li>Ascent Solar (<a href=\"https://seekingalpha.com/symbol/ASTI\" title=\"Ascent Solar Technologies, Inc.\">OTC:ASTI</a> <font color=\"green\">+23.5%</font>) has skyrocketed after announcing Wal-mart <a href=\"http://www.walmart.com/search/search-ng.do?ic=16_0&amp;Find=Find&amp;search_query=enerplex&amp;Find=Find&amp;search_constraint=0\" target=\"_blank\">is now selling</a> its EnerPlex solar accessories. (PR)</li>\n<li>As is its custom, Wal-mart is selling the items at a discount. For example, Ascent's EnerPlex Surfr solar/battery-powered cases, which <a href=\"http://www.frys.com/product/7611447?source=googleps&amp;gclid=CMvc7Jvu-rkCFe1_Qgod1U0AVg\" target=\"_blank\">go for $69.99</a> on Fry's Electronics's site, are being <a href=\"http://www.walmart.com/ip/EnerPlex-Surfr-Solar-and-Battery-Powered-Phone-Case-for-Samsung-Galaxy-S3-White/28240640\" target=\"_blank\">sold for $56.88</a> on Wal-mart's site.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1312742\" data-linked=\"Ascent Solar accessories available at Wal-mart, shares fly\" data-tweet=\"$ASTI $ASTI-OLD - Ascent Solar accessories available at Wal-mart, shares fly https://seekingalpha.com/news/1312742-ascent-solar-accessories-available-at-wal-mart-shares-fly?source=tweet\" data-url=\"https://seekingalpha.com/news/1312742-ascent-solar-accessories-available-at-wal-mart-shares-fly\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312692\" data-ts=\"1380809550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIMT\" target=\"_blank\">CIMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312692-cimatron-jumps-on-bullish-chardan-coverage-launch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cimatron jumps on bullish Chardan coverage launch</a></h4><ul>\n<li>Chardan's <a href=\"http://www.streetinsider.com/Analyst+Comments/Chardan+Capital+Markets+Starts+Cimatron+Ltd.+%28CIMT%29+at+Buy%3B+Foray+Into+3D+Could+be+Game-Changer/8746496.html\" target=\"_blank\">Jay Srivasta</a> is starting volatile Cimatron (<a href=\"https://seekingalpha.com/symbol/CIMT\" title=\"Cimatron, Limited\">CIMT</a> <font color=\"green\">+5.6%</font>) with a Buy and $10 PT. He calls the company's planned 3D printing efforts \"a game-changer (if well executed), and argues Cimatron's CAD/CAM software expertise makes it well-positioned to benefit from rapid 3D printing <a href=\"http://techcrunch.com/2013/10/02/gartner-3d-printer-market-forecast/\" target=\"_blank\">industry growth</a>.</li>\n<li>Separately, Cimatron announces it has struck a deal with simulation software firm MachineWorks to integrate the company's <a href=\"http://www.machineworks.com/polygonica.htm\" target=\"_blank\">Polygonica</a> 2D/3D modeling tech within the next release of its mainstay <a href=\"http://www.cimatron.com/homepage.aspx?FolderID=5\" target=\"_blank\">CimatronE</a> CAD software platform.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1312692\" data-linked=\"Cimatron jumps on bullish Chardan coverage launch\" data-tweet=\"$CIMT - Cimatron jumps on bullish Chardan coverage launch https://seekingalpha.com/news/1312692-cimatron-jumps-on-bullish-chardan-coverage-launch?source=tweet\" data-url=\"https://seekingalpha.com/news/1312692-cimatron-jumps-on-bullish-chardan-coverage-launch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312672\" data-ts=\"1380809394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312672-sarepta-jumps-after-wms-presentation-shows-weak-dystrophin-data-for-drisapersen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta jumps after WMS presentation shows weak dystrophin data for drisapersen</a></h4><ul>\n<li>Sarepta Therapeutics (<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"green\">+6.2%</font>) trades notably higher in morning action.</li>\n<li>The shares look to be getting a boost from <a href=\"https://seekingalpha.com/currents/search?query=drisapersen\" target=\"_blank\">drisapersen</a> (<a href=\"https://seekingalpha.com/symbol/RNA\" title=\"Prosensa Holding N.V.\">RNA</a>, <a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a>) data presented Wednesday at the World Muscle Society.</li>\n<li>Ultimately, the  dystrophin production data for drisapersen (see <a href=\"https://twitter.com/ianestepan/status/385489793112891392/photo/1\" target=\"_blank\">here</a>) was weak \u2014 only 12-29% of patients realized an increase in the precursor to dystrophin.</li>\n<li>Baird <a href=\"http://www.streetinsider.com/Analyst+Comments/Baird+Maintains+Buy+on+Sarepta+Therapeutic+%28SRPT%29/8746755.html\" target=\"_blank\">maintains</a> a Buy on SRPT. Price target is $63.</li>\n<li>RBC is apparently out <a href=\"https://twitter.com/ianestepan/status/385726990575087616\" target=\"_blank\">incrementally more positive</a> on SRPT as well.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1312672\" data-linked=\"Sarepta jumps after WMS presentation shows weak dystrophin data for drisapersen\" data-tweet=\"$SRPT $SRPT $RNA - Sarepta jumps after WMS presentation shows weak dystrophin data for drisapersen https://seekingalpha.com/news/1312672-sarepta-jumps-after-wms-presentation-shows-weak-dystrophin-data-for-drisapersen?source=tweet\" data-url=\"https://seekingalpha.com/news/1312672-sarepta-jumps-after-wms-presentation-shows-weak-dystrophin-data-for-drisapersen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312652\" data-ts=\"1380809049\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AWAY\" target=\"_blank\">AWAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312652-homeaway-spikes-potentially-on-m-and-a-speculation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HomeAway spikes, potentially on M&amp;A speculation</a></h4><ul><li>Shares of HomeAway (<a href='https://seekingalpha.com/symbol/AWAY' title='HomeAway, Inc.'>AWAY</a> <font color='green'>+5.3%</font>) spike on nearly a full day's 3-month average volume, potentially on <a href=\"https://twitter.com/OptionCast/status/385764819984322560\" target=\"_blank\">M&amp;A speculation</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1312652\" data-linked=\"HomeAway spikes, potentially on M&amp;A speculation\" data-tweet=\"$AWAY - HomeAway spikes, potentially on M&amp;A speculation https://seekingalpha.com/news/1312652-homeaway-spikes-potentially-on-m-and-a-speculation?source=tweet\" data-url=\"https://seekingalpha.com/news/1312652-homeaway-spikes-potentially-on-m-and-a-speculation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312602\" data-ts=\"1380808693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312602-a-roundup-of-tech-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes</a></h4><ul>     <li>Alcatel-Lucent (ALU <font color='red'>-0.4%</font>) has been cut to Market Perform by Raymond James. BMO issued <a href=\"https://seekingalpha.com/currents/post/1278512\" target=\"_blank\">a similar downgrade</a> three weeks ago.</li>     <li>Mellanox (<a href='https://seekingalpha.com/symbol/MLNX' title='Mellanox Technologies, Ltd.'>MLNX</a> <font color='green'>+3.9%</font>) has been upgraded to Buy by Craig-Hallum.</li>     <li>Riverbed (<a href='https://seekingalpha.com/symbol/RVBD' title='Riverbed Technology, Inc.'>RVBD</a> <font color='red'>-0.1%</font>) has been upgraded to Sector Perform by RBC.</li>     <li>China Mobile (<a href='https://seekingalpha.com/symbol/CHL' title='China Mobile Limited'>CHL</a> <font color='red'>-1.6%</font>) has been cut to Underperform by BofA/Merrill.</li>     <li>Yandex (<a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a> <font color='green'>+3.7%</font>) has been started at Buy by Citi.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1312602\" data-linked=\"A roundup of tech ratings changes\" data-tweet=\"$NOK $NOK $MLNX - A roundup of tech ratings changes https://seekingalpha.com/news/1312602-a-roundup-of-tech-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1312602-a-roundup-of-tech-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312562\" data-ts=\"1380807991\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTM\" target=\"_blank\">TTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312562-tata-motors-on-the-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tata Motors on the move</a></h4><ul> <li>Tata Motors (<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a> <font color='green'>+3.8%</font>) is seeing a nice little bounce after shares put in some early gains in Bombay trading.</li> <li>A <a href=\"http://www.moneycontrol.com/news/market-outlook/festive-season-to-guide-trend-buy-tata-motors-mm-nomura_962608.html\" target=\"_blank\">solid endorsement</a> from Nomura is helping to lift sentiment on the company.</li> <li>Nomura on Indian automakers: \"The top pick at this point would be Tata Motors.\"</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1312562\" data-linked=\"Tata Motors on the move\" data-tweet=\"$TTM - Tata Motors on the move https://seekingalpha.com/news/1312562-tata-motors-on-the-move?source=tweet\" data-url=\"https://seekingalpha.com/news/1312562-tata-motors-on-the-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312532\" data-ts=\"1380807852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBAY\" target=\"_blank\">EBAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312532-paypal-tests-amazon-prime-like-service-groupon-hires-prime-vp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PayPal tests Amazon Prime-like service; Groupon hires Prime VP</a></h4><ul>\n<li>PayPal (<a href=\"https://seekingalpha.com/symbol/EBAY\" title=\"eBay Inc.\">EBAY</a> <font color=\"red\">-0.1%</font>) is <a href=\"https://www.paypal-forward.com/commerce/paypal-just-made-it-easy-to-get-free-2-day-shipping/\" target=\"_blank\">partnering</a> with a handful of retailers to provide free two-day shipping within the U.S. for a limited time on purchases paid via PayPal. <a href=\"https://www.paypal-pages.com/2-day-shipping/\" target=\"_blank\">Partners include </a>Levi's, Sports Authority, Aeropostale, and iRobot.</li>\n<li>No word on whether PayPal plans to expand the test, or eventually offer some kind of permanent service (perhaps for a fee). The test appears squarely aimed at Amazon Prime (<a href=\"https://seekingalpha.com/symbol/AMZN\" title=\"Amazon.com, Inc.\">AMZN</a> <font color=\"red\">-0.2%</font>), which provides free two-day shipping on millions of items on Amazon's site, in exchange for a $79/year fee. Amazon was <a href=\"http://www.businessinsider.com/amazon-prime-10-million-members-morningstar-2013-3\" target=\"_blank\">estimated</a> in March to have 10M Prime subs.</li>\n<li>Separately, Groupon (<a href=\"https://seekingalpha.com/symbol/GRPN\" title=\"Groupon, Inc.\">GRPN</a> <font color=\"green\">+2.4%</font>) announces it has hired Amazon Prime VP Robbie Schweitzer to be its SVP of operations. The company has also hired Angie's List (<a href=\"https://seekingalpha.com/symbol/ANGI\" title=\"ANGI Homeservices Inc.\">ANGI</a> <font color=\"red\">-14.7%</font>) e-commerce exec David Kerr to help create \"a marketplace experience for Groupon customers to find, schedule and purchase deals from local service providers\" (will likely compete with Angie's).</li>\n<li>Two other hires: A VP to head the <a href=\"https://seekingalpha.com/currents/post/1115022\" target=\"_blank\">Groupon Reserve</a> high-end restaurant reservation/deals service (Lisa Kennedy), and one to head Groupon's commercial finance ops (Hoke Horne).</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1311452\" target=\"_blank\">Yesterday:</a> Angie's List testing price cuts</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1312532\" data-linked=\"PayPal tests Amazon Prime-like service; Groupon hires Prime VP\" data-tweet=\"$EBAY $EBAY $AMZN - PayPal tests Amazon Prime-like service; Groupon hires Prime VP https://seekingalpha.com/news/1312532-paypal-tests-amazon-prime-like-service-groupon-hires-prime-vp?source=tweet\" data-url=\"https://seekingalpha.com/news/1312532-paypal-tests-amazon-prime-like-service-groupon-hires-prime-vp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312512\" data-ts=\"1380807473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVRA\" target=\"_blank\">SVRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312512-canaccord-like-mast-therapeutics-on-sickle-cell-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canaccord like Mast Therapeutics on sickle cell potential</a></h4><ul>     <li>Canaccord starts Mast Therapeutics (MSTX <font color=\"green\">+15%</font>) at Buy.</li>     <li>Analyst Ritu Baral likes MST-188's (Orphan designation in Europe) chances in sickle cell, and says EPIC \"is well designed enough to to support FDA and EMA approval by itself if ... successful.\" Expect read-out in 2016.</li>     <li>Baral sees U.S. market launch in 2017 and peak sales of around $400M by 2023.</li>     <li>Price target is $3, which, even counting this morning's double-digit gains, translates into a <font color=\"green\">477%</font> upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1312512\" data-linked=\"Canaccord like Mast Therapeutics on sickle cell potential\" data-tweet=\"$SVRA - Canaccord like Mast Therapeutics on sickle cell potential https://seekingalpha.com/news/1312512-canaccord-like-mast-therapeutics-on-sickle-cell-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/1312512-canaccord-like-mast-therapeutics-on-sickle-cell-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312442\" data-ts=\"1380806748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312442-another-way-to-slice-up-valuation-on-tesla-motors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another way to slice up valuation on Tesla Motors</a></h4><ul> <li>It's <a href=\"https://twitter.com/lwhiteman_TD/status/385753710858473472\" target=\"_blank\">small wonder</a> an isolated car fire of a Model S would cause shares of Tesla Motors (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a>) to flinch so easily, reasons transportation analyst Lou Whiteman.</li> <li>Putting pencil to paper, Whiteman works out a market valuation on Tesla of $1M per projected 2013 sale compared to $23K per GM sale in the U.S. (forget about global for the moment).</li> <li>The comparison might not be relevant with Tesla gearing up for mass production, but it does give another solid reason why shares could continue to be skittish at their lofty levels.</li> <li>TSLA <font color=\"red\">-2.5%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1312442\" data-linked=\"Another way to slice up valuation on Tesla Motors\" data-tweet=\"$TSLA - Another way to slice up valuation on Tesla Motors https://seekingalpha.com/news/1312442-another-way-to-slice-up-valuation-on-tesla-motors?source=tweet\" data-url=\"https://seekingalpha.com/news/1312442-another-way-to-slice-up-valuation-on-tesla-motors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312412\" data-ts=\"1380806591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NPSP\" target=\"_blank\">NPSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312412-bofa-initiates-nps-pharmaceuticals-at-buy-sees-big-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofA initiates NPS Pharmaceuticals at Buy, sees big upside</a></h4><ul>     <li>BofA <a href=\"http://www.streetinsider.com/Hot+New+Coverage/BofAMerrill+Lynch+Starts+NPS+Pharmaceuticals+Inc.+%28NPSP%29+at+Buy/8746499.html\" target=\"_blank\">starts</a> NPS Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NPSP\" title=\"NPS Pharmaceuticals, Inc.\">NPSP</a>) at Buy.</li>     <li>It looks like BofA <a href=\"https://twitter.com/bradloncar/status/385751310475075584\" target=\"_blank\">is valuing</a> Gattex (which is apparently seeing some off-label reimbursement of late) at around $23/share and <a href=\"https://seekingalpha.com/currents/search?query=natpara\" target=\"_blank\">Natpara</a> (which may end up having higher peak sales than <a href=\"https://seekingalpha.com/currents/search?query=gattex\" target=\"_blank\">Gattex</a> if you buy Leerink's thinking) at $20.</li>     <li>Adding another $2 for royalties brings the price target to $45, representing a <font color=\"green\">35%</font> premium to Wednesday's close.</li>     <li>NPSP <font color=\"green\">+1.4%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1312412\" data-linked=\"BofA initiates NPS Pharmaceuticals at Buy, sees big upside\" data-tweet=\"$NPSP - BofA initiates NPS Pharmaceuticals at Buy, sees big upside https://seekingalpha.com/news/1312412-bofa-initiates-nps-pharmaceuticals-at-buy-sees-big-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/1312412-bofa-initiates-nps-pharmaceuticals-at-buy-sees-big-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312392\" data-ts=\"1380806137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312392-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CAMP' title='CalAmp Corp.'>CAMP</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CIMT' title='Cimatron, Limited'>CIMT</a> <font color='green'>+8%</font>. GALE <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/OCZ' title='OCZ Technology Group Inc'>OCZ</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CHU' title='China Unicom &#40;Hong Kong&#41; Limited'>CHU</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/VVUS' title='Vivus, Inc.'>VVUS</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ANGI' title='ANGI Homeservices Inc.'>ANGI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/WSR' title='Whitestone REIT'>WSR</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1312392\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$CAMP $CIMT $SLS - Premarket Gainers / Losers https://seekingalpha.com/news/1312392-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1312392-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312382\" data-ts=\"1380806016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312382-omeros-settles-with-insurer-unlocks-new-orphan-gpcrs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omeros settles with insurer, unlocks new orphan GPCRs,</a></h4><ul>     <li>Omeros (NASDAQ:<a href=\"https://seekingalpha.com/symbol/OMER\" title=\"Omeros Corporation\">OMER</a>) jumps <font color=\"green\">4%</font> premarket.</li>     <li>The company has settled with Carolina Casualty Insurance over coverage obligations. OMER will receive a $12.5M payment by October 25. (PR) </li>     <li>OMER also says it \"has identified compounds that functionally interact with each of six additional orphan G protein-coupled receptors.\"</li>     <li>The significance there is that once the compounds have been identified, new drugs that target the receptors can potentially be developed. Consistent with this, these orphan GPCRs are dubbed \"druggable.\" (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1312382\" data-linked=\"Omeros settles with insurer, unlocks new orphan GPCRs,\" data-tweet=\"$OMER - Omeros settles with insurer, unlocks new orphan GPCRs, https://seekingalpha.com/news/1312382-omeros-settles-with-insurer-unlocks-new-orphan-gpcrs?source=tweet\" data-url=\"https://seekingalpha.com/news/1312382-omeros-settles-with-insurer-unlocks-new-orphan-gpcrs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312262\" data-ts=\"1380804387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312262-no-delay-for-vascepa-fda-meeting-amarin-pops\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">No delay for Vascepa FDA meeting, Amarin pops</a></h4><ul>     <li>Amarin (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMRN\" title=\"Amarin Corporation PLC\">AMRN</a>) shareholders needn't fear the government shutdown \u2014 at least not as it relates to a proposed high triglycerides and mixed dyslipidemia indication for <a href=\"https://seekingalpha.com/currents/search?query=vascepa\" target=\"_blank\">Vascepa</a>.</li>     <li>The company says the FDA advisory committee meeting to discuss the sNDA will take place as scheduled on October 16 \"despite the current Federal Government lapse in appropriations.\" (PR)</li>     <li>AMRN <font color=\"green\">+3.5%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1312262\" data-linked=\"No delay for Vascepa FDA meeting, Amarin pops\" data-tweet=\"$AMRN - No delay for Vascepa FDA meeting, Amarin pops https://seekingalpha.com/news/1312262-no-delay-for-vascepa-fda-meeting-amarin-pops?source=tweet\" data-url=\"https://seekingalpha.com/news/1312262-no-delay-for-vascepa-fda-meeting-amarin-pops\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312212\" data-ts=\"1380803181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLNE\" target=\"_blank\">CLNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312212-clean-energy-says-it-is-first-commercial-distributor-of-transportation-fuel-made-from-waste\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clean Energy says it is first commercial distributor of transportation fuel made from waste</a></h4><ul>     <li>Clean Energy Fuels (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CLNE\" title=\"Clean Energy Fuels Corp.\">CLNE</a>) says it is now the first company to commercially distribute a renewable natural gas vehicle fuel - called Redeem - made from waste streams such as landfills, large dairies and sewage plants directly to fleets in the U.S. and at the 35 public CLNE stations in California.</li>     <li>CLNE says \"it's a landmark day\"; investors seem to disagree, as shares <font color=\"red\">-3.5%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1312212\" data-linked=\"Clean Energy says it is first commercial distributor of transportation fuel made from waste\" data-tweet=\"$CLNE - Clean Energy says it is first commercial distributor of transportation fuel made from waste https://seekingalpha.com/news/1312212-clean-energy-says-it-is-first-commercial-distributor-of-transportation-fuel-made-from-waste?source=tweet\" data-url=\"https://seekingalpha.com/news/1312212-clean-energy-says-it-is-first-commercial-distributor-of-transportation-fuel-made-from-waste\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312192\" data-ts=\"1380803030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312192-vivus-jumps-on-cowen-leerink-qsymia-ip-hopes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivus jumps on Cowen, Leerink, Qsymia IP hopes</a></h4><ul>     <li>Vivus (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"green\">+8.6%</font>) looks set for another strong session, rising <font color=\"green\">5.4%</font> in premarket trading as Cowen <a href=\"http://www.streetinsider.com/Upgrades/Cowen+Upgrades+Vivus+%28VVUS%29+to+Outperform/8746348.html\" target=\"_blank\">upgrades</a> the shares to Outperform.</li>     <li>Price target is $19.</li>     <li>Also out with commentary is Leerink, where Marko Kozul <a href=\"http://www.streetinsider.com/Analyst+Comments/Leerink+Keeps+VIVUS%2C+Inc.+%28VVUS%29+at+Outperform%3B+Expects+Mid-Oct.+Qsymia+Update/8746347.html\" target=\"_blank\">likes the prospect</a> of extended intellectual property coverage for <a href=\"https://seekingalpha.com/currents/search?query=qsymia\" target=\"_blank\">Qsymia</a> and is looking forward to a mid-October update on the weight-loss drug.</li>     <li>The stock <a href=\"https://seekingalpha.com/currents/post/1310392\" target=\"_blank\">got a big lift</a> Wednesday from BofA's comments on the company's progress in finding a Qsymia partner.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1312192\" data-linked=\"Vivus jumps on Cowen, Leerink, Qsymia IP hopes\" data-tweet=\"$VVUS - Vivus jumps on Cowen, Leerink, Qsymia IP hopes https://seekingalpha.com/news/1312192-vivus-jumps-on-cowen-leerink-qsymia-ip-hopes?source=tweet\" data-url=\"https://seekingalpha.com/news/1312192-vivus-jumps-on-cowen-leerink-qsymia-ip-hopes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312152\" data-ts=\"1380802245\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLS\" target=\"_blank\">SLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312152-galena-biopharma-launches-abstral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galena Biopharma launches Abstral</a></h4><ul>     <li>As expected, Galena Biopharma (GALE) launches Abstral in the U.S. (PR)</li>     <li>The sublingual fentanyl tablets are the company's first commercial product and, along with <a href=\"https://seekingalpha.com/currents/search?query=neuvax\" target=\"_blank\">NeuVax</a>, comprise the bull thesis for the stock.</li>     <li>GALE <font color=\"green\">+4.4%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1312152\" data-linked=\"Galena Biopharma launches Abstral\" data-tweet=\"$SLS - Galena Biopharma launches Abstral https://seekingalpha.com/news/1312152-galena-biopharma-launches-abstral?source=tweet\" data-url=\"https://seekingalpha.com/news/1312152-galena-biopharma-launches-abstral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1312062\" data-ts=\"1380800880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1312062-bernstein-whipsawed-cuts-blackberry-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bernstein whipsawed; cuts BlackBerry to Sell</a></h4><ul>     <li>\"Our detailed analysis of the <a href=\"https://seekingalpha.com/currents/post/1310862\" target=\"_blank\">recent filing</a> of Blackberry (BBRY) reveals a cash position far worse than we modeled,\" writes Bernstein's Pierre Ferragu, <a href=\"http://www.streetinsider.com/Downgrades/Bernstein+Downgrades+BlackBerry+%28BBRY%29+to+Underperform%2C+%244.50+PT/8746324.html\" target=\"_blank\">downgrading the stock </a>to Sell with a $4.50 price target. \"We believe BlackBerry is likely to burn close to $2B in the next 6 quarters on a standalone basis, leading the company into material liquidity problems.\"</li>     <li>Any floor valuation on the company is \"irrelevant,\" he continues, and the Fairfax bid has almost no chance to secure financing. Only a \"remotely possible\" strategic acquisition keeps the price target from being $0.</li>     <li>Whipsaw city: Ferragu upgraded BlackBerry on Monday.</li>     <li>Shares <font color=\"red\">-2%</font> premarket to $7.80.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1312062\" data-linked=\"Bernstein whipsawed; cuts BlackBerry to Sell\" data-tweet=\"$BB - Bernstein whipsawed; cuts BlackBerry to Sell https://seekingalpha.com/news/1312062-bernstein-whipsawed-cuts-blackberry-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/1312062-bernstein-whipsawed-cuts-blackberry-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1311872\" data-ts=\"1380792552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1311872-asian-eu-shares-mixed-u-s-futures-flat-to-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asian, EU shares mixed, U.S. futures flat-to-lower</a></h4><ul>   <li>\n<a href=\"http://www.reuters.com/article/2013/10/03/markets-global-idUSL6N0HT0WA20131003\" target=\"_blank\">Global stocks</a> are mixed as the deadlock in Washington continues but also following strong services PMI data from China, the eurozone and the U.K.</li>    <li>The thought that the U.S. shutdown will put off Fed tapering has apparently provided some lift somewhere, although U.S. stock futures don't seem to be benefiting from that line of thought.</li>    <li>Japan <font color=\"red\">-0.1%</font>, Hong Kong <font color=\"green\">+1%</font>, India <font color=\"green\">+1.9%</font>.</li>    <li>EU Stoxx 50 <font color=\"red\">-0.1%</font>, London <font color=\"green\">+0.2%</font>, Paris <font color=\"red\">-0.3%</font>, Frankfurt <font color=\"red\">-0.1%</font>, Milan <font color=\"green\">+0.2%</font>, Madrid <font color=\"red\">-0.2%</font>.</li>    <li>U.S. stock futures: Dow <font color=\"red\">-0.4%</font>. S&amp;P <font color=\"red\">-0.1%</font>. Nasdaq flat.</li>    <li>ETFs: EFA, IEFA, VEA, ADRD, MFLA, EFO, MFSA, EFU, PDN, PIZ, EFZ, PXF, EFG, PFA, EFV, DZK, DPK, IDLV, DTH, DWM, URTH, FDTS, ADRA, AIA, VPL, ASDR, AAXJ, AXJS, EPP, GMF, GMFS, AXJL, UXJ, JPX, PAF, ASEA, EEMA, DVYA</li> </ul><div class=\"tiny-share-widget\" data-id=\"1311872\" data-linked=\"Asian, EU shares mixed, U.S. futures flat-to-lower\" data-tweet=\"Asian, EU shares mixed, U.S. futures flat-to-lower https://seekingalpha.com/news/1311872-asian-eu-shares-mixed-u-s-futures-flat-to-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/1311872-asian-eu-shares-mixed-u-s-futures-flat-to-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:29 AM </div></div></li>","count":30,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}